Suggestions
Sid Viswanathan
Co-Founder & CEO at Truepill
Sid Viswanathan is a serial entrepreneur and co-founder of Truepill, a digital health platform that aims to transform consumer healthcare. Here are some key details about his background and career:
Education and Early Career
Sid graduated from Carnegie Mellon University with a B.S. in Mechanical Engineering and Biomedical Engineering.4 After college, he joined Johnson & Johnson's Global Operations Leadership Development program, where he worked in the medical device and pharmaceutical sectors for about 2.5 years.4
Entrepreneurial Journey
CardMunch
In 2009, Sid co-founded CardMunch, a mobile app for scanning business cards.4 The company was acquired by LinkedIn in 2011, just over a year after its founding.4
Following the acquisition, Sid joined LinkedIn as a Product Manager, where he worked for nearly 4 years.4 During his time there, he led the integration and growth of CardMunch within LinkedIn.
Truepill
In 2016, Sid co-founded Truepill with Umar Afridi.1 Truepill is a digital health platform that aims to transform consumer healthcare by connecting telehealth, diagnostics, and pharmacy services.5
Leadership at Truepill
Sid initially served as Co-Founder and President of Truepill from 2016 to January 2022.4 In February 2022, he took on the role of CEO.2 However, as of August 2023, Sid announced that he had stepped down from his position as CEO of Truepill.3
Current Venture
As of his latest LinkedIn update, Sid is now the Founder & Co-CEO at Alchemy, a company building on-site pharmacies for 340B covered entities.34
Sid Viswanathan's career demonstrates his expertise in entrepreneurship, particularly in the digital health and technology sectors. His experience spans from founding startups to leading a rapidly growing company in the competitive healthcare technology space.
Highlights
Check out SHACK15 at the Ferry Buikding in SF if you haven’t been here before.
It will be interesting to see how far this UnitedHealth Group anti-trust investigation will go. From our conversation with folks in Washington, this seems to have more teeth to it than your garden variety ant-trust case. Although this is physician group focussed, we are encouraged by the fact that Lina Khan and the DOJ are actively talking to independent pharmacies to understand the real-life challenges they face against the Big 3 PBMs every single day.
I refer to this as the “hand-to-hand combat” that safety net providers and pharmacies deal with daily, just to stay alive and serve patients who desperately need their medications affordably, on time, and at the location of their choosing. You would think that these are basic rights of a patient and pharmacy, but it is not the case, and the current state is unacceptable and needs reform.
Here’s a snapshot of what this looks like on-the-ground.
#DefendPatientChoice #SafetyNet
